Matthew Bonaparte Selected Research

Dengue Vaccines

1/2022	Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening.
1/2022	Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with a new dengue rapid diagnostic test: a retrospective analysis of phase 3 efficacy trials.
1/2022	Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority study.
1/2021	Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial.
1/2021	Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials.
1/2021	Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.
1/2021	Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection.
1/2021	CYD Tetravalent Dengue Vaccine Performance by Baseline Immune Profile (Monotypic/Multitypic) in Dengue-Seropositive Individuals.
1/2021	Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America.
1/2020	The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew Bonaparte Research Topics

Disease

20	Dengue (Dengue Fever) 01/2022 - 01/2016
6	Infections 01/2022 - 12/2019
3	Severe Dengue 01/2022 - 01/2021
2	Yellow Fever 01/2020 - 02/2017
2	Japanese Encephalitis 01/2020 - 03/2014
1	Breakthrough Infections 01/2021
1	HIV Infections (HIV Infection) 08/2007

Drug/Important Bio-Agent (IBA)

18	Dengue VaccinesIBA 01/2022 - 01/2016
8	VaccinesIBA 01/2021 - 03/2014
7	Immunoglobulin G (IgG)IBA 01/2022 - 01/2018
5	Neutralizing AntibodiesIBA 01/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	EnzymesIBA 03/2020 - 07/2018
3	ImmunosorbentsIBA 03/2020 - 07/2018
2	AntibodiesIBA 02/2017 - 03/2014
1	CYD-TDV vaccineIBA 01/2022
1	EpitopesIBA 01/2021
1	Japanese Encephalitis VaccinesIBA 01/2020
1	SolutionsIBA 12/2019
1	Immunoglobulin M (IgM)IBA 01/2018
1	AntigensIBA 01/2018
1	CytokinesIBA 01/2016
1	LigandsIBA 08/2007
1	Natural Killer Cell ReceptorsIBA 08/2007

Therapy/Procedure

1	Injections 01/2020